1
|
Kuzemczak M, Lipiecki J, Jeyalan V, Farhat H, Kleczyński P, Legutko J, Minten L, Bennett J, Poels E, Dens J, Spyridopoulos I, Kunadian V, Pawłowski T, Gil R, Egred M, Zaman A, Alkhalil M. Clinical outcomes of coronary intravascular lithotripsy in patients with stent failure (COIL registry). Int J Cardiol 2023; 391:131274. [PMID: 37598907 DOI: 10.1016/j.ijcard.2023.131274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/12/2023] [Revised: 07/25/2023] [Accepted: 08/17/2023] [Indexed: 08/22/2023]
Abstract
BACKGROUND Intravascular lithotripsy (IVL) has been demonstrated to be an effective treatment of calcified de novo coronary lesions. Safety data on the use of IVL within stented segments are lacking. We sought to evaluate the safety, feasibility, and long-term outcomes of IVL in patients with stent failure. METHODS This was a retrospective multi-centre registry that included consecutive patients with stent failure who had undergone IVL treatment. The primary efficacy endpoint was procedural success defined as residual stenosis <30% (determined by quantitative coronary angiography analysis) in patients who survived hospital admission without in-hospital adverse events. Major adverse cardiovascular events (MACE) were defined as the composite endpoints of cardiovascular death, spontaneous myocardial infarction, and target vessel revascularisation at one-year follow up. RESULTS 102 patients were included in this study. Mean age was 73 ± 9 years and 81% were male. The duration from previous stent implantation and IVL treatment was 24 (interquartile range 7-76) months, of which 10.8% received IVL for acute under-expanded stent. IVL treatment allowed significant improvement in both minimal lumen diameter (1.14 ± 0.60 to 2.53 ± 0.59, P < 0.001) and degree of stenosis (66.8 ± 19.9 to 20.3 ± 11.3%, P < 0.001). The rate of procedural success was 78.4% (80/102 of patients). The one-year MACE was 15.7%. Ostial disease (HR 5.16; 95% CI 1.19 to 22.33; P = 0.028) and lesion length (HR 1.05; 95% CI 1.01 to 1.10; P = 0.010) were independently associated with one-year MACE. CONCLUSIONS In patients with stent failure, IVL is a safe and feasible treatment for this high-risk group.
Collapse
Affiliation(s)
- Michał Kuzemczak
- Department of Cardiology, Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland; Poznań University of Medical Sciences, Division of Emergency Medicine, Poznań, Poland
| | - Janusz Lipiecki
- Centre de Cardiologie Interventionnelle, Pôle Santé République, Clermont-Ferrand, France
| | - Visvesh Jeyalan
- Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne, UK
| | - Hicham Farhat
- Centre de Cardiologie Interventionnelle, Pôle Santé République, Clermont-Ferrand, France
| | - Paweł Kleczyński
- Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Cracow, Poland; Clinical Department of Interventional Cardiology, John Paul II Hospital, Cracow, Poland
| | - Jacek Legutko
- Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, Cracow, Poland; Clinical Department of Interventional Cardiology, John Paul II Hospital, Cracow, Poland
| | - Lennert Minten
- Department of Cardiovascular Medicine, KU Leuven, University Hospitals Leuven, Leuven, Belgium
| | - Johan Bennett
- Department of Cardiovascular Medicine, KU Leuven, University Hospitals Leuven, Leuven, Belgium
| | | | | | - Ioakim Spyridopoulos
- Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom
| | - Vijay Kunadian
- Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom
| | - Tomasz Pawłowski
- Department of Cardiology, Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland
| | - Robert Gil
- Department of Cardiology, Central Clinical Hospital of the Ministry of Interior and Administration, Warsaw, Poland
| | - Mohaned Egred
- Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom
| | - Azfar Zaman
- Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom
| | - Mohammad Alkhalil
- Cardiothoracic Centre, Freeman Hospital, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, United Kingdom.
| |
Collapse
|
2
|
Farag M, van den Buijs D, Loh SX, Poels E, Ameloot K, Janssens L, Bennett J, Tahon J, Dens J, Egred M. Long-term clinical outcomes of excimer laser coronary atherectomy for the management of recurrent in-stent restenosis. J Invasive Cardiol 2023; 35:E365-E374. [PMID: 37769620] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 09/30/2023]
Abstract
BACKGROUND Recurrent in-stent restenosis (ISR) remains a serious problem. Optimal modification of the underlying mechanism during index percutaneous coronary intervention (PCI) is key to prevent ISR. Excimer laser coronary atherectomy (ELCA) has its own indications and is among others used in recurrent ISR in case of stent underexpansion and/or diffuse neointimal hyperplasia. We aimed to assess the long-term clinical outcomes of ELCA for the management of recurrent ISR. METHODS A multicenter, retrospective observational study was conducted. Patients with recurrent ISR who were additionally treated with ELCA were included. The primary outcome was major adverse cardiac events (MACE) defined as a composite of cardiovascular death, myocardial infarction, stroke, target lesion revascularization at 12 months, and longer term. RESULTS Between 2014 and 2022, 51 patients underwent PCI with the additional use ELCA for recurrent ISR. Primary outcome occurred in 6 patients (11.8%) at 12 months and in 12 patients (23.5%) at a median follow-up of 4 (1-6) years. Technical and procedural success were achieved in 92% and 90% of cases, respectively. Coronary perforation occurred in 2 patients as a result of distal wire perforation, but was not ELCA-related. There were no in-hospital MACE. CONCLUSIONS ELCA appears to be a safe method with acceptable long-term results for the management of recurrent ISR.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | - Mohaned Egred
- Cardiothoracic Department, Freeman Hospital, Newcastle-Upon-Tyne, Tyne and Wear, NE7 7DN, United Kingdom.
| |
Collapse
|
3
|
Poels E, Vanhaverbeke M, van den Buijs D, Cottens D, Ameloot K, Lesizza P, McCutcheon K, Bennet J, Dens J. Postdischarge prognostic significance of periprocedural myocardial injury after percutaneous intervention of chronic total occlusion. Open Heart 2022; 9:openhrt-2022-002113. [PMID: 36600648 PMCID: PMC9748983 DOI: 10.1136/openhrt-2022-002113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/04/2022] [Accepted: 11/14/2022] [Indexed: 12/15/2022] Open
Abstract
BACKGROUND The postdischarge prognostic implication of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention (PCI) of a chronic total occlusion (CTO) remains scarcely studied. AIMS The aim of this study is to assess the prognostic value of periprocedural myocardial injury, defined by increased high-sensitive troponin T (hs-TnT) levels according to updated guidelines, after CTO PCI. METHODS Between September 2011 and April 2020, 726 patients undergoing CTO PCI at 2 Belgian referral centres were prospectively included and divided into 4 groups based on postprocedural hs-TnT levels (unelevated; ≥5 times the upper limit of normal (ULN); ≥35 times the ULN; ≥70 times the ULN). Postprocedural hs-TnT levels were subsequently related to patient and procedural characteristics, 1-year major adverse cardiac and cerebrovascular events (MACCE; excluding in-hospital MACCE) as well as 1-year mortality. RESULTS At 1 year follow-up (FU), elevated hs-TnT≥5 times and ≥35 times the ULN were associated with higher MACCE rates (p=0.001; p=0.007, respectively). In addition, they also resulted in a higher 1-year mortality rate (p=0.009;p=0.021, respectively). Patients with increased hs-TnT≥5 times the ULN (35% of patients) more frequently had signs of more advanced atherosclerotic disease (previous CABG p<0.001; stroke p≤0.001 and peripheral vascular disease p<0.001) and had higher procedural complexity (Japanese CTO Score p=<0.001, stent length>48 mm p<0.001, procedure time p<0.001). Antegrade wire escalation did not result in lower event rate of postdischarge MACCE compared with the other CTO crossing techniques combined (p=0.158). CONCLUSION Periprocedural myocardial injury was associated with a significantly higher rate of MACCE and all-cause mortality after 12 months of FU.
Collapse
Affiliation(s)
- Ella Poels
- Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Limburg, Belgium
| | - Maarten Vanhaverbeke
- Department of Cardiovascular Medicine, KU Leuven University Hospitals Leuven, Leuven, Flanders, Belgium
| | | | - Daan Cottens
- Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Limburg, Belgium
| | - Koen Ameloot
- Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Limburg, Belgium
| | - Pierluigi Lesizza
- Department of Cardiovascular Medicine, KU Leuven University Hospitals Leuven, Leuven, Flanders, Belgium
| | - Keir McCutcheon
- Department of Cardiovascular Medicine, KU Leuven University Hospitals Leuven, Leuven, Flanders, Belgium
| | - Johan Bennet
- Department of Cardiovascular Medicine, KU Leuven University Hospitals Leuven, Leuven, Flanders, Belgium
| | - Joseph Dens
- Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Limburg, Belgium
| |
Collapse
|
4
|
Silva J, Videira RF, Koop AM, Duygu B, Ottaviani L, Poels E, Leite S, van De Kolk KW, du Marchie Sarvaas GJ, Bartelds B, Lourenço A, Nascimento D, Pinto-do-Ó P, Falcão-Pires I, Goumans MJ, Berger R, da Costa Martins PA. MicroRNA-199b is involved in both LV and RV pathological remodeling through distinct molecular mechanisms. J Mol Cell Cardiol 2022. [DOI: 10.1016/j.yjmcc.2022.08.097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
5
|
Cottens D, Ferdinande B, Polad J, Vrolix M, Ameloot K, Hendrickx I, Poels E, Maeremans J, Dens J. FFR pressure wire comparative study for drift: piezo resistive versus optical sensor. Am J Cardiovasc Dis 2022; 12:42-52. [PMID: 35291508 PMCID: PMC8918737] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 06/30/2021] [Accepted: 02/07/2022] [Indexed: 06/14/2023]
Abstract
BACKGROUND This study aimed to assess the stability of pressure derived fractional flow reserve (FFR) measurement and the handling performance of the OptoWire Deux with an optical pressure sensor relative to the PressureWire X with piezo resistive pressure sensors. METHODS This multicenter centre observational study included 50 patients between June 2017 and November 2018 undergoing a diagnostic coronary angiography with FFR measurement of moderate to severe lesions. The reliability of FFR measurement measured with the OptoWire Deux relative to the PressureWire X in each lesion was assessed by the presence of drift. Handling characteristics for both pressure wires were assessed by a 5-point scale and by comparing the time between equalization and crossing the distal target lesion. RESULTS Hundred and sixteen measurements in 50 patients were performed. Very stable and reliable FFR measurements with the optical sensors were registered, relative to the piezo resistive pressure sensors. There is statistically significant difference in favor of the OptoWire Deux over the PressureWire X (P=0.001). However, the differences are small, when drift values were compared as continuous variables, no statistically significant difference was found for both directional (P=0.435) as for absolute drift (P=0.058). CONCLUSIONS In patients undergoing FFR measurement, both optical sensor pressure wires (Optowire Deux) as piezo resistive sensor pressure wires (PressureWire X) generate stable and reliable pressure and thus FFR measurement. The optical pressure sensor is less susceptible for drift relative to the piezo resistive pressure sensor, but the difference is within an acceptable range.
Collapse
Affiliation(s)
- Daan Cottens
- Department of Cardiology, Hospital Oost-LimburgGenk, Belgium
| | - Bert Ferdinande
- Department of Cardiology, Hospital Oost-LimburgGenk, Belgium
| | - Jawed Polad
- Department of Cardiology, Hospital Jeroen Bosch’s HertogenboschThe Netherlands
| | - Mathias Vrolix
- Department of Cardiology, Hospital Oost-LimburgGenk, Belgium
| | - Koen Ameloot
- Department of Cardiology, Hospital Oost-LimburgGenk, Belgium
| | - Ief Hendrickx
- Department of Cardiology, Hospital Oost-LimburgGenk, Belgium
| | - Ella Poels
- Department of Cardiology, Hospital Oost-LimburgGenk, Belgium
| | - Joren Maeremans
- Faculty of Medicine and Life Sciences, Universiteit HasseltBelgium
| | - Jo Dens
- Department of Cardiology, Hospital Oost-LimburgGenk, Belgium
- Faculty of Medicine and Life Sciences, Universiteit HasseltBelgium
| |
Collapse
|
6
|
Koop AMC, Duygu B, Ottaviani L, Poels E, Van De Kolk KW, Du Marchie Sarvaas GJ, Bartelds B, Lourenco AP, Nascimento DS, Pinto- Do-O P, Falcao-Pires I, Berger RMF, Da Costa Martins PA. 4929Contribution of miR-199b to right ventricular remodelling due to pressure overload. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.4929] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- A M C Koop
- University of Groningen, University Medical Center Groningen, Department of Pediatrics, Center for Congenital Heart Diseases, Groningen, Netherlands
| | - B Duygu
- Cardiovascular Research Institute Maastricht (CARIM), Department of Cardiology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands
| | - L Ottaviani
- Cardiovascular Research Institute Maastricht (CARIM), Department of Cardiology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands
| | - E Poels
- Cardiovascular Research Institute Maastricht (CARIM), Department of Cardiology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands
| | - K W Van De Kolk
- University Medical Center Groningen, the Central Animal Facility, Groningen, Netherlands
| | - G J Du Marchie Sarvaas
- University of Groningen, University Medical Center Groningen, Department of Pediatrics, Center for Congenital Heart Diseases, Groningen, Netherlands
| | - B Bartelds
- Erasmus Medical Center, Sophia Children's Hospital, Department of Pediatrics, Division of Cardiology, Rotterdam, Netherlands
| | - A P Lourenco
- INEB - Instituto de Engenharia Biomédica, Universidade do Porto, 5ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal
| | - D S Nascimento
- INEB - Instituto de Engenharia Biomédica, Universidade do Porto, 5ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal
| | - P Pinto- Do-O
- INEB - Instituto de Engenharia Biomédica, Universidade do Porto, 5ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal
| | - I Falcao-Pires
- INEB - Instituto de Engenharia Biomédica, Universidade do Porto, 5ICBAS - Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto, Portugal
| | - R M F Berger
- University of Groningen, University Medical Center Groningen, Department of Pediatrics, Center for Congenital Heart Diseases, Groningen, Netherlands
| | - P A Da Costa Martins
- Cardiovascular Research Institute Maastricht (CARIM), Department of Cardiology, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands
| |
Collapse
|
7
|
Kappenstein C, Wahdan T, Duprez D, Zaki M, Brands D, Poels E, Bliek A. Permanganic acid: A novel precursor for the preparation of managanese oxide catalysts. ACTA ACUST UNITED AC 1995. [DOI: 10.1016/s0167-2991(06)81810-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/07/2023]
|